A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus

Part of paid clinical trials in Glendale, Arizona.

Sponsor
Novo Nordisk A/S
Study ID
NCT02773368
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • insulin degludec/liraglutide — DRUG
    IDegLira will be given subcutaneously ( s.c., under the skin) once daily.
  • insulin glargine — DRUG
    IGlar will be given subcutaneously ( s.c., under the skin) once daily.

Study Details

This trial is conducted globally. The aim of this trial is comparing glycaemic control and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine (IGlar) as add-on therapy to SGLT2i (sodium-glucose cotransporter 2 inhibitors) in subjects with type 2 diabetes mellitus.

Key Dates

Start date
May 23, 2016
Status verified
Aug 2020
Primary completion
Sep 26, 2017
Completion
Oct 23, 2017

Study Design

Enrollment
420 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: IDegLira
  • Active Comparator: IGlar

Primary Outcome Measure

Change in HbA1c (Glycosylated Haemoglobin) [ Time Frame: Week 0, Week 26 ]

Locations (24)

FacilityCityStateZIPSite coordinators
Novo Nordisk Investigational SiteGlendaleArizona85308-
Novo Nordisk Investigational SiteLa JollaCalifornia92037-
Novo Nordisk Investigational SiteMission ViejoCalifornia92691-
Novo Nordisk Investigational SiteNorthridgeCalifornia91325-
Novo Nordisk Investigational SitePalm SpringsCalifornia92262-
Novo Nordisk Investigational SiteSan RamonCalifornia94583-
Novo Nordisk Investigational SiteBoynton BeachFlorida33472-
Novo Nordisk Investigational SiteChieflandFlorida32626-
Novo Nordisk Investigational SiteSkokieIllinois60077-
Novo Nordisk Investigational SiteAvonIndiana46123-
Novo Nordisk Investigational SiteRockvilleMaryland20852-
Novo Nordisk Investigational SiteLas VegasNevada89118-
Novo Nordisk Investigational SiteTeaneckNew Jersey07666-
Novo Nordisk Investigational SiteAlbanyNew York12206-
Novo Nordisk Investigational SiteWest SenecaNew York14224-
Novo Nordisk Investigational SiteWhitevilleNorth Carolina28472-
Novo Nordisk Investigational SiteMasonOhio45040-6815-
Novo Nordisk Investigational SiteGreerSouth Carolina29651-
Novo Nordisk Investigational SiteBristolTennessee37620-7352-
Novo Nordisk Investigational SiteAustinTexas78731-
Novo Nordisk Investigational SiteHoustonTexas77081-
Novo Nordisk Investigational SiteLongviewTexas75605-
Novo Nordisk Investigational SiteSan AntonioTexas78228-3419-
Novo Nordisk Investigational SiteKenoshaWisconsin53144-

Find similar trials in Glendale, AZ

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Novo Nordisk Investigational Site· Glendale, AZNovo Nordisk Investigational Site· La Jolla, CANovo Nordisk Investigational Site· Mission Viejo, CANovo Nordisk Investigational Site· Northridge, CANovo Nordisk Investigational Site· Palm Springs, CANovo Nordisk Investigational Site· San Ramon, CA

Related Studies